BioSpace News Archive

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the execution of territory exclusive distribution agreements in Singapore and South Korea.

Amgen announced that its Board of Directors declared a $1.76 per share dividend for the fourth quarter of 2021.

Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), today announced that it will host a conference call on Thursday, November 4, 2021 at 4:30 PM ET to discuss its financial results and provide a business update for the third quarter 2021.

Accuray Incorporated, announced preliminary financial results for the first quarter of fiscal 2022 ended September 30, 2021.

Naviswiss, a Swiss-based medical technology company receives clearance from the FDA to market Naviplan in the United States.

IVERIC bio, Inc., announced that it is commencing an underwritten public offering of $125.0 million of shares of its common stock.

Geron Corporation reported that it has granted non-statutory stock options to purchase an aggregate of 80,000 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted today to recommend the use of a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level for people aged 65 and older.

Johnson & Johnson (the Company) (NYSE: JNJ) today announced that the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP), has recommended its COVID-19 vaccine as a booster for all eligible individuals who receive an authorized COVID-19 vaccine.

IVERIC bio, Inc., announced the pricing of an upsized underwritten public offering of 9,000,000 shares of its common stock at a price to the public of $16.75 per share, less underwriting discounts and commissions.